Citigroup Maintains Neutral on RXO, Raises Price Target to $30

RXO, Inc. Common Stock

RXO, Inc. Common Stock

RXO

0.00

Citigroup analyst Ariel Rosa maintains RXO (NYSE: RXO) with a Neutral and raises the price target from $24 to $30.